Company Filing History:
Years Active: 2001
Title: Sydney Brünner: Innovator in Oligonucleotide Technology
Introduction
Sydney Brünner is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of molecular biology through her innovative work on oligonucleotide tags. Her inventions have the potential to revolutionize the way researchers track, identify, and sort various classes of molecules.
Latest Patents
Sydney Brünner holds a patent for her invention titled "Oligonucleotide tags for sorting and identification." This invention provides a method for tracking, identifying, and sorting classes or subpopulations of molecules using oligonucleotide tags. The oligonucleotide tags consist of a minimally cross-hybridizing set of oligonucleotides, each comprising a plurality of subunits ranging from 3 to 9 nucleotides in length. An important aspect of her invention is the ability to sort polynucleotides by specifically hybridizing tags attached to the polynucleotides to their complements on solid phase supports. This method is particularly useful in large-scale parallel operations, such as DNA sequencing and mRNA fingerprinting.
Career Highlights
Sydney Brünner is currently associated with Lynx Therapeutics, Inc., where she continues to advance her research and development in molecular biology. Her work has garnered attention for its innovative approach to sorting and identifying molecules, which is crucial for various applications in genetic research and biotechnology.
Conclusion
Sydney Brünner is a pioneering inventor whose work on oligonucleotide tags has the potential to significantly impact molecular biology and genetic research. Her contributions are paving the way for advancements in large-scale DNA sequencing and other related fields.